Sigilon Therapeutics Probability of Future Stock Price Finishing Over 21.11
| SGTXDelisted Stock | USD 21.11 0.33 1.54% |
Sigilon |
Sigilon Therapeutics Target Price Odds to finish over 21.11
The tendency of Sigilon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 21.11 | 90 days | 21.11 | about 5.84 |
Based on a normal probability distribution, the odds of Sigilon Therapeutics to move above the current price in 90 days from now is about 5.84 (This Sigilon Therapeutics probability density function shows the probability of Sigilon Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Sigilon Therapeutics has a beta of -9.34. This usually implies as returns on its benchmark rise, returns on holding Sigilon Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Sigilon Therapeutics is expected to outperform its benchmark. In addition to that Sigilon Therapeutics has an alpha of 7.2486, implying that it can generate a 7.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Sigilon Therapeutics Price Density |
| Price |
Predictive Modules for Sigilon Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sigilon Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sigilon Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sigilon Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sigilon Therapeutics is not an exception. The market had few large corrections towards the Sigilon Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sigilon Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sigilon Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 7.25 | |
β | Beta against Dow Jones | -9.34 | |
σ | Overall volatility | 6.98 | |
Ir | Information ratio | 0.11 |
Sigilon Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sigilon Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sigilon Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sigilon Therapeutics is not yet fully synchronised with the market data | |
| Sigilon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.94 M. Net Loss for the year was (43.56 M) with loss before overhead, payroll, taxes, and interest of (24.69 M). | |
| Sigilon Therapeutics currently holds about 88.21 M in cash with (51.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. |
Sigilon Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sigilon Stock often depends not only on the future outlook of the current and potential Sigilon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sigilon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.4 M | |
| Cash And Short Term Investments | 69.6 M |
Sigilon Therapeutics Technical Analysis
Sigilon Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Sigilon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sigilon Therapeutics. In general, you should focus on analyzing Sigilon Stock price patterns and their correlations with different microeconomic environments and drivers.
Sigilon Therapeutics Predictive Forecast Models
Sigilon Therapeutics' time-series forecasting models is one of many Sigilon Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sigilon Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sigilon Therapeutics
Checking the ongoing alerts about Sigilon Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sigilon Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sigilon Therapeutics is not yet fully synchronised with the market data | |
| Sigilon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.94 M. Net Loss for the year was (43.56 M) with loss before overhead, payroll, taxes, and interest of (24.69 M). | |
| Sigilon Therapeutics currently holds about 88.21 M in cash with (51.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon Therapeutics' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |